GGrantIndex
← Leaderboards

Weidong Xiao

Indiana University Indianapolis

$16,949,600
Attributed
$18,031,561
Total exposure
14
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,945,670 · 15

By mechanism

R01$10,563,382 · 5
U54$9,536,424 · 5
P01$4,845,864 · 5

Top collaborators

Others in their field

Top investigators on “Gene Therapy

Research focus

Gene TherapyHemophilia ACellsVectorAdeno-Associated Viral VectorGenesImmune ResponseFactor ViiiClinical TrialsTechnologyRecombinant Adeno-Associated Virus (Raav)Gene ExpressionBaseLeadEngineeringSafetyProductionMolecularInnovationProteinsQuality Of LifeCostF8 GeneGenome

Grant awards (57)

Biology of Subgenomic AAV Vector Particles$472,398
P01 · FY2025 · HL · contact PI
Molecular Virology Core$354,297
P01 · FY2025 · HL · contact PI
Biology of Subgenomic AAV Vector Particles$464,029
P01 · FY2024 · HL · contact PI
Molecular Virology Core$348,023
P01 · FY2024 · HL · contact PI
Biology of Subgenomic AAV Vector Particles$515,589
P01 · FY2023 · HL · contact PI
Molecular Virology Core$386,692
P01 · FY2023 · HL · contact PI
Center for the Investigation of Factor VIII Inhibitors and Glycosylation$1,323,844
U54 · FY2022 · HL · contact PI
Biology of Subgenomic AAV Vector Particles$521,105
P01 · FY2022 · HL · contact PI
Molecular Virology Core$390,829
P01 · FY2022 · HL · contact PI
Project-005$270,798
U54 · FY2022 · HL · contact PI
Project-004$258,200
U54 · FY2022 · HL · contact PI
Center for the Investigation of Factor VIII Inhibitors and Glycosylation$1,346,699
U54 · FY2021 · HL · contact PI
Project-005$274,914
U54 · FY2021 · HL · contact PI
Project-004$260,888
U54 · FY2021 · HL · contact PI
Center for the Investigation of Factor VIII Inhibitors and Glycosylation$1,404,536
U54 · FY2020 · HL · contact PI
Project-005$286,892
U54 · FY2020 · HL · contact PI
Project-004$271,250
U54 · FY2020 · HL · contact PI
Center for the Investigation of Factor VIII Inhibitors and Glycosylation$1,384,185
U54 · FY2019 · HL · contact PI
Development of highly efficient factor VIII mini-gene therapy$480,959
R01 · FY2019 · HL · contact PI
Temple Project 1: Genetic characterization of factor VIII Inhibitors and glydosylation patterns$258,515
U54 · FY2019 · HL · contact PI
CORE B: Skills Development Core$230,710
U54 · FY2019 · HL · contact PI
Center for the Investigation of Factor VIII Inhibitors and Glycosylation$1,454,845
U54 · FY2018 · HL · contact PI
Development of highly efficient factor VIII mini-gene therapy$482,625
R01 · FY2018 · HL · contact PI
Temple Project 1: Genetic characterization of factor VIII Inhibitors and glydosylation patterns$268,858
U54 · FY2018 · HL · contact PI
CORE B: Skills Development Core$241,290
U54 · FY2018 · HL · contact PI
Development of highly efficient factor VIII mini-gene therapy$487,271
R01 · FY2017 · HL · contact PI
Development of highly efficient factor VIII mini-gene therapy$491,780
R01 · FY2016 · HL · contact PI
Novel adeno-associated virus vector production system development$450,654
R01 · FY2016 · HL · contact PI
Novel adeno-associated virus vector production system development$443,895
R01 · FY2015 · HL · contact PI
Novel adeno-associated virus vector production system development$441,641
R01 · FY2014 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$337,410
R01 · FY2014 · HL · contact PI
Novel adeno-associated virus vector production system development$429,023
R01 · FY2013 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$327,769
R01 · FY2013 · HL · contact PI
Novel adeno-associated virus vector production system development$450,654
R01 · FY2012 · HL · contact PI
Molecular engineering of factor VIII gene for rAAV delivery$417,285
R01 · FY2012 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$344,295
R01 · FY2012 · HL · contact PI
Molecular engineering of factor VIII gene for rAAV delivery$421,500
R01 · FY2011 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$344,296
R01 · FY2011 · HL · contact PI
Molecular engineering of factor VIII gene for rAAV delivery$337,500
R01 · FY2010 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$327,713
R01 · FY2010 · HL · contact PI
Molecular engineering of factor VIII gene for rAAV delivery$41,996
R01 · FY2010 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$359,391
R01 · FY2009 · HL · contact PI
CORE--Vector$295,488
P01 · FY2009 · HL · contact PI
Molecular engineering of factor VIII gene for rAAV delivery$270,000
R01 · FY2009 · HL · contact PI
Molecular engineering of factor VIII gene for rAAV delivery$74,025
R01 · FY2009 · HL · contact PI
Molecular engineering of factor VIII gene for rAAV delivery$364,302
R01 · FY2008 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$359,939
R01 · FY2008 · HL · contact PI
CORE--Vector$281,090
P01 · FY2008 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$360,484
R01 · FY2007 · HL · contact PI
CORE--Vector$278,087
P01 · FY2007 · HL · contact PI
Molecular Biology of Recombinant AAV Genomes$372,375
R01 · FY2006 · HL · contact PI
CORE--Vector$267,006
P01 · FY2006 · HL · contact PI
Molecular and Cellular Characterization of AAV1 Vector$340,000
R01 · FY2005 · HL
CORE--Vector$271,231
P01 · FY2005 · HL
Molecular and Cellular Characterization of AAV1 Vector$340,000
R01 · FY2004 · HL
Molecular and Cellular Characterization of AAV1 Vector$340,000
R01 · FY2003 · HL
Molecular and Cellular Characterization of AAV1 Vector$324,600
R01 · FY2002 · HL